SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson's disease.

Trends Neurosci · 2026-03-12

DOI: 10.1016/j.tins.2026.02.003PMID: 41820102

Check source for accessResearch Support, Non-U.S. Gov't; Review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

The motor symptoms of Parkinson's disease are linked to age-dependent degeneration of dopamine neurons. Traditionally, the loss of these neurons has been thought to stem mainly from cell-autonomous cellular dysfunctions. However, there is growing evidence suggesting that it could result from complex interactions between cell-autonomous and non-cell-autonomous mechanisms. This review article examines evidence for cell-autonomous mechanisms linked to mitochondrial, lysosomal, or proteasomal perturbations and for non-cell-autonomous processes arising from glial and peripheral immune cells. We discuss how these pathways can converge to create chronic cellular stress and trigger cell death mechanisms. Beyond highlighting apoptosis as a key mode of degeneration, we consider the contribution of other mechanisms, including pyroptosis and ferroptosis. Understanding the relative dominance of these mechanisms across disease stages and patient subgroups could help guide the development of mechanism-based neuroprotective strategies.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.